IHS Holding
IHS
8.44
0.00
0.00%
IHS Holding
US · IHS
#2537 by market cap
Listed 2021
8.44
0.00
0.00%
Live - 5344 symbols - heartbeat 50s ago
· 2026-10-07 19:54
After-hours
8.44
0.00%
- Market cap
- 2.86B
- P/E (TTM)i
- 20.59
- P/Bi
- -15.72
- EPSi
- 0.42
- Div yieldi
- 0.00%
- 52W posi
- 84%
Reader sentiment
Are you bullish or bearish on IHS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -0.62, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.59% YoY
Margins
- Gross margin
- 55.41%
- Operating margin
- 37.02%
- Net margin
- 9.08%
Key ratios & quality
- Enterprise valuei
- 5.23B
- Altman Z-Scorei
- -0.62
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.17B | 1.23B | 1.40B | 1.58B | 1.96B | 1.93B | 1.53B | 1.58B |
| Gross profit | 401.36M | 420.09M | 564.73M | 672.34M | 804.30M | 888.70M | 793.60M | 876.60M |
| Selling & admin expenses | 125.19M | 495.04M | 180.23M | 241.83M | 286.77M | 296.50M | 265.60M | 275.80M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 220.04M | -109.99M | 360.03M | 444.95M | 505.73M | 572.00M | 516.40M | 585.70M |
| Pretax profit | -86.02M | -409.97M | -152.85M | -8.14M | -543.98M | -1.81B | -1.41B | 690.80M |
| Tax | 46.75M | 13.52M | 169.83M | 17.98M | -75.01M | 102.80M | 69.30M | 86.40M |
| Net profit | -132.77M | -423.49M | -322.68M | -26.12M | -468.97M | -1.99B | -1.64B | 126.80M |
| Basic EPS | 0 | -1 | -1 | 0 | -1 | -6 | -5 | 0 |
| Diluted EPS | -0.40 | -1.29 | -0.98 | -0.09 | -1.39 | -5.93 | -4.90 | 0.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 392.10M | 388.20M | 455.10M | 254.00M | 415.40M | 428.60M |
| Gross profit | 218.30M | 217.10M | 216.10M | 212.30M | 231.80M | 207.10M |
| Selling & admin expenses | 62.30M | 67.20M | 67.50M | 63.80M | 101.90M | 124.50M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 153.10M | 146.80M | 133.60M | 157.40M | 124.30M | 81.50M |
| Pretax profit | 91.00M | 101.00M | 188.40M | 365.50M | 117.20M | 25.80M |
| Tax | 44.10M | 48.50M | 41.00M | -28.50M | 50.10M | 40.90M |
| Net profit | 30.70M | 32.30M | 147.40M | -83.60M | 77.00M | -7.50M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.10 | 0.10 | 0.44 | -0.23 | 0.22 | -0.03 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | 1.22B | 989.32M | 1.43B | 1.25B | 972.61M | 924.30M | 2.50B |
| Cash & ST investments | -- | 898.80M | 585.42M | 916.49M | 514.08M | 293.82M | 578.00M | 825.70M |
| Inventory | -- | 48.71M | 49.22M | 42.02M | 74.22M | 40.59M | 30.60M | 42.10M |
| Total assets | -- | 4.16B | 4.45B | 5.54B | 6.32B | 5.36B | 4.25B | 4.49B |
| Total current liabilities | -- | 566.46M | 683.64M | 830.56M | 1.27B | 1.22B | 648.20M | 1.20B |
| Short-term debt | -- | 122.00M | 214.37M | 258.18M | 525.35M | 545.31M | 210.80M | 356.40M |
| Long-term debt | -- | 1.95B | 2.02B | 2.40B | 2.91B | 3.06B | 3.22B | 2.84B |
| Total liabilities | -- | 2,734,389,000.00 | 3,223,452,000.00 | 3,798,600,000.00 | 4,960,503,000.00 | 5,017,356,000.00 | 4,560,900,000.00 | 4,579,400,000.00 |
| Total equity | -- | 1.43B | 1.22B | 1.74B | 1.36B | 347.35M | -314.40M | -89.80M |
| Retained earnings | -- | -2.51B | -2.84B | -2.86B | -3.32B | -5.29B | -6.94B | -6.80B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 961.20M | 984.50M | 1.07B | 2.50B | 2.69B | 2.35B |
| Cash & ST investments | 629.00M | 531.80M | 647.60M | 825.70M | 940.50M | 1.07B |
| Inventory | 44.30M | 39.00M | 40.80M | 42.10M | 41.10M | 46.50M |
| Total assets | 4.42B | 4.49B | 4.68B | 4.49B | 4.67B | 4.36B |
| Total current liabilities | 755.50M | 641.20M | 667.10M | 1.20B | 1.34B | 1.22B |
| Short-term debt | 299.10M | 194.90M | 232.40M | 356.40M | 385.20M | 389.90M |
| Long-term debt | 3.17B | 3.14B | 3.14B | 2.84B | 2.81B | 2.79B |
| Total liabilities | 4,600,500,000.00 | 4,588,200,000.00 | 4,645,200,000.00 | 4,579,400,000.00 | 4,689,400,000.00 | 4,542,600,000.00 |
| Total equity | -184.40M | -98.40M | 38.10M | -89.80M | -23.70M | -182.60M |
| Retained earnings | -6.89B | -6.88B | -6.72B | -6.80B | -6.72B | -6.73B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 462.31M | 641.94M | 635.26M | 750.19M | 907.30M | 853.50M | 729.40M | 936.20M |
| Depreciation & amortization | 317.30M | 384.51M | 408.66M | 382.88M | 468.90M | 435.60M | 362.80M | 375.90M |
| Free cash flow | 84.28M | 383.66M | 406.06M | 347.71M | 347.93M | 254.70M | 460.30M | 684.10M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock buybacks / issuance | -- | -- | -- | 378.00M | 0 | -10.00M | 0 | 0 |
| Ending cash balance | 633.45M | 898.80M | 585.42M | 916.49M | 514.08M | 293.80M | 578.00M | 853.30M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 200.30M | 237.70M | 251.30M | 246.90M | 228.60M | 150.00M |
| Depreciation & amortization | 89.40M | 89.00M | -- | -- | 55.80M | 56.20M |
| Free cash flow | 143.70M | 191.40M | 176.90M | 170.30M | 182.20M | 112.20M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 629.00M | 533.10M | 651.50M | 853.30M | 966.50M | 1.09B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -29.61 | -24.39 | -1.85 | -33.92 | -318.48 | -- | -- |
| ROA %i | -- | -10.17 | -7.48 | -0.52 | -7.81 | -33.83 | -33.85 | 3.28 |
| ROIC %i | -- | -7.78 | -4.78 | 2.90 | -3.94 | -36.15 | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -81.71 | -- | -- |
| EBIT margin %i | 8.76 | -16.12 | 4.23 | 13.21 | -11.02 | -67.47 | -67.64 | 64.09 |
| FCF / sales %i | 7.22 | 31.17 | 28.94 | 22.01 | 17.74 | 11.98 | 26.90 | 43.24 |
| Current ratioi | -- | 2.16 | 1.45 | 1.72 | 0.99 | 0.80 | 1.43 | 2.08 |
| Quick ratioi | -- | 2.04 | 1.28 | 1.62 | 0.93 | 0.69 | 1.34 | 0.82 |
| Debt / assetsi | -- | 53.79 | 56.61 | 53.86 | 62.49 | 76.66 | 91.85 | 78.18 |
| LT debt / equityi | -- | 148.10 | 190.38 | 179.37 | 302.25 | 3,247.70 | -- | -- |
| Interest coveragei | 0.54 | -0.94 | 0.28 | 0.96 | -0.66 | -3.21 | -2.56 | 3.14 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 10.59 | 16.79 | 11.12 | -1.12 | -6.91 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | 60.38 | -3.21 | -14.40 | 9.80 | 25.28 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -1.01 | 2.46 | 10.07 | 3.28 | 4.10 | 3.21 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 26.93 | 35.55 | 55.69 | 64.09 | 64.85 | 59.14 |
| FCF / sales %i | 34.34 | 41.30 | 44.27 | 43.24 | 45.01 | 39.09 |
| Current ratioi | 1.27 | 1.54 | 1.60 | 2.08 | 2.01 | 1.93 |
| Quick ratioi | 1.18 | 1.26 | 1.34 | 0.82 | 0.82 | 1.01 |
| Debt / assetsi | 89.61 | 85.40 | 83.18 | 78.18 | 75.06 | 80.04 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 1.04 | 1.39 | 2.33 | 3.14 | 3.21 | 2.94 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.